Childhood Myopia 

              In recent years, myopia (otherwise known as nearsightedness) has become a growing concern affecting up to 50% of the adult population in the U.S. In children the prevalence of myopia is progressing from 25% to 42% between 1971 and 1999.1 Some research has shown that “kids who are exposed to less outdoor daylight in early childhood are more likely to become myopic.”Those with a high degree of myopia are at an increased risk of developing more serious eye-related conditions like cataracts and glaucoma.3 While the cause of myopia is not exactly known, it occurs when the eye grows too long, thus changing the focus of the images on the retina to just in front of the retina (Figure 1,2), making it more difficult to focus on objects far away.3 Myopia is measured in diopters (D), which indicate the lens strength required for correction; high myopia is considered -5.0 to 6.0 diopters or greater.

Figure 1 (Source: National Eye Institute) .

                                                                                                                                                                                                        Figure 2 (Source: National Eye Institute) .

  1. Pineles SL. Kraker RT. Atropine for the Prevention of Myopia Progression in Children. American Academy of Ophthalmology. 2017; Vol.124, Number 12
  2. Kate Rauch. (2017, August31) Low Dose Atropine for Kids with Myopia. American Academy of Ophthalmology. Retrieved June 27, 2018 from hops://
  3. Facts About Myopia. (2017 October.) National Eye Institute. Retrieived June 27,2018 from hops://

Information contained on these materials is provided as an informational aide and for reference use only. The content herein is not intended to be, act as, or replace medical advice or diagnosis for individual health conditions nor is it making evaluations as to the risks or benefits of particular preparations. Please consult a licensed healthcare professional about diagnosis and treatment. Information and statements on this material have not been evaluated by the Food and Drug Administration.

*Low Dose Atropine (0.05%, 0.025% and 0.01% ) are prescribed off label and has not been studied or  approved by the FDA